Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
NCT Number: NCT03571841
This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
The purpose of this research is to study the effectiveness of an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of cancer recurrence. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The 4-hour group session will be structured around three 60-minute modules and creation of a personal action plan
One month following the group session, women will receive a telephone booster session (<15 minutes). This brief telephone check-in is intended to help women review progress with their individualized action-plan, problem-solve around continuing problems, and plan for maintenance moving forward.
Time frame: Paired t-test (Wilcoxon signed-rank test) Baseline to 2 Month Follow-up
Baseline to 2 Month Follow-up Paired t-test (Wilcoxon signed-rank test)
Time frame: Baseline to 2 Months
Paired t-test (Wilcoxon signed-rank test)
Dana-Farber Cancer Institute
Other
Sexual Health and Rehabilitation After Ovarian Suppression Treatment (SHARE-OS): An Educational Intervention for Young Breast Cancer Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07334626
Aromatase Inhibitors, Bone Diseases
Banhā, Benha, Egypt
View Trial DetailsNCT07367334
Breast Cancer Survivors, Cortisol
Chennai, Tamil Nadu, India
View Trial DetailsNCT04262180
Behavior, Breast Cancer Survivors
Chicago, Illinois, United States
View Trial DetailsNCT05690295
Behavior, Breast Cancer Survivors
Temuco, Chile
View Trial Details